This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Journey of Inventor Chun-Hung Kuo
Introduction: Chun-Hung Kuo, an accomplished inventor based in New Taipei, Taiwan, has made significant contributions in the field of drug delivery systems. With a keen focus on enhancing the efficacy of cell penetrating peptides, Kuo's innovative work addresses the challenges of drug formulation and delivery.
Latest Patents: Chun-Hung Kuo holds a patent titled "Oxidative modification improves the drugability of cell penetrating peptides as drug carriers." This groundbreaking invention introduces a cell penetrating peptide dimer created through oxidative modification, where each monomer is linked by a disulfide bond. The innovation significantly improves the drugability of the peptide dimer by enhancing stability, reducing proteolysis, maintaining permeability, and increasing heparan sulfate binding specificity. These modified peptide products serve as effective drug carriers for targeted therapy.
Career Highlights: Throughout his career, Kuo has dedicated himself to advancing biomedical research and applications. His innovative approach has paved the way for more effective drug delivery systems, making substantial impacts in therapeutic treatments.
Collaborations: Chun-Hung Kuo has collaborated with colleagues Yu-Min Lin and Wei-Chen Chen, demonstrating the power of teamwork in innovation. Their combined expertise has facilitated the development of groundbreaking solutions and approaches in the field of drug delivery.
Conclusion: The work of Chun-Hung Kuo highlights the importance of innovation in addressing medical challenges. His pioneering patent not only reflects his ingenuity but also contributes to the ongoing advancement of targeted therapy, showcasing the potential of cell penetrating peptides in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile